Patent · US Active

Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter

US7678553B2 · kind B2 · utility

1Cited by

7References

1Claims

0Family size

Assignee

BIOGAIA AB · SE

Inventors

Eamonn Connolly · Lidingö, SE
Bo Mollstam · Lerum, SE

Key dates

Filing date	Dec 3, 2008
Grant date	Mar 16, 2010
Priority date	—
Expiry date	Dec 3, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/225
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.